Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.

The pharmacokinetics of Zn-phthalocyanine (Zn-Pc) in mice bearing a transplanted MS-2 fibrosarcoma has been studied using dipalmitoyl-phosphatidylcholine (DPPC) liposomes and low density lipoproteins (LDL) as drug delivery systems. LDL induce a higher Zn-Pc uptake by the tumour and improve the selectivity of tumour targeting as compared to DPPC liposomes. Experimental photodynamic therapy (PDT) of the MS-2 fibrosarcoma has been performed using liposome-delivered Zn-Pc and the efficiency of tumour necrosis has been measured following four different irradiation protocols. We found that Zn-Pc doses as low as 0.07-0.35 mg kg-1 are sufficient for inducing an efficient tumour response that is linearly dependent on the injected dose. The amount of Zn-Pc in the tumour decreases very slowly as a function of time, hence PDT gives satisfactory results even if performed at relatively long time intervals after administration.

[1]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[2]  G. Zalar,et al.  Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin. , 1977, Archives of dermatology.

[3]  H. Kato,et al.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.

[4]  C. Gomer,et al.  Photophysics and Dosimetry of Photoradiation Therapy , 1984 .

[5]  T. Dougherty Photodynamic therapy (PDT) of malignant tumors. , 1984, Critical reviews in oncology/hematology.

[6]  J. Rousseau,et al.  Synthesis, tissue distribution and tumor uptake of 99mTc- and 67Ga-tetrasulfophthalocyanine. , 1985, The International journal of applied radiation and isotopes.

[7]  S. Vitols,et al.  Selective uptake of a toxic lipophilic anthracycline derivative by the low-density lipoprotein receptor pathway in cultured fibroblasts. , 1985, Journal of medicinal chemistry.

[8]  E. Ben-hur,et al.  The phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[9]  D. Phillips,et al.  EHPnet: Doing a World of Good , 1998, Environmental Health Perspectives.

[10]  N. Brasseur,et al.  BIOLOGICAL ACTIVITIES OF PHTHALOCYANINES—IV. TYPE II SENSITIZED PHOTOOXIDATION OF L‐TRYPTOPHAN AND CHOLESTEROL BY SULFONATED METALLO PHTHALOCYANINES , 1986 .

[11]  L. Dubertret,et al.  In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts , 1986, FEBS letters.

[12]  D. Kessel PROPOSED STRUCTURE OF THE TUMOR‐LOCALIZING FRACTION OF HPD (HEMATOPORPHYRIN DERIVATIVE) , 1986, Photochemistry and Photobiology.

[13]  D. Kessel SITES OF PHOTOSENSITIZATION BY DERIVATIVES OF HEMATOPORPHYRIN , 1986, Photochemistry and photobiology.

[14]  J. Spikes PHTHALOCYANINES AS PHOTOSENSITIZERS IN BIOLOGICAL SYSTEMS AND FOR THE PHOTODYNAMIC THERAPY OF TUMORS , 1986, Photochemistry and photobiology.

[15]  E. Reddi,et al.  Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice. , 1987, British Journal of Cancer.

[16]  H. Barr,et al.  Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. , 1987, British Journal of Cancer.

[17]  F. Hetzel,et al.  CLINICAL LASER PHOTODYNAMIC THERAPY IN THE TREATMENT OF BLADDER CARCINOMA , 1987, Photochemistry and photobiology.

[18]  E. Reddi,et al.  Spectroscopic studies on Zn(II)-phthalocyanine in homogeneous and microheterogeneous systems. , 1987, Journal of inorganic biochemistry.

[19]  E. Reddi,et al.  ULTRASTRUCTURAL STUDIES ON THE MECHANISM OF THE PHOTODYNAMIC THERAPY OF TUMORS , 1987, Photochemistry and photobiology.

[20]  H. Barr,et al.  ALUMINUM SULFONATED PHTHALOCYANINE DISTRIBUTION IN RODENT TUMORS OF THE COLON, BRAIN and PANCREAS , 1987, Photochemistry and photobiology.

[21]  W. Potter,et al.  DRUG AND LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR CELL CLONOGENICITY AND HISTOLOGIC CHANGES , 1987, Photochemistry and photobiology.

[22]  D. Kessel,et al.  TUMOR LOCALIZATION AND PHOTOSENSITIZATION BY SULFONATED DERIVATIVES OF TETRAPHENYLPORPHINE , 1987, Photochemistry and photobiology.

[23]  R. Langlois,et al.  BIOLOGICAL ACTIVITIES OF PHTHALOCYANINES—V. PHOTODYNAMIC THERAPY OF EMT‐6 MAMMARY TUMORS IN MICE WITH SULFONATED PHTHALOCYANINES , 1987, Photochemistry and photobiology.

[24]  E. Reddi,et al.  THE PRODUCTION OF SINGLET MOLECULAR OXYGEN BY ZINC(II) PHTHALOCYANINE IN ETHANOL AND IN UNILAMELLAR VESICLES. CHEMICAL QUENCHING AND PHOSPHORESCENCE STUDIES , 1988, Photochemistry and photobiology.